DK657689D0 - Middel med biologisk virkning paa tarmslimhinden - Google Patents

Middel med biologisk virkning paa tarmslimhinden

Info

Publication number
DK657689D0
DK657689D0 DK657689A DK657689A DK657689D0 DK 657689 D0 DK657689 D0 DK 657689D0 DK 657689 A DK657689 A DK 657689A DK 657689 A DK657689 A DK 657689A DK 657689 D0 DK657689 D0 DK 657689D0
Authority
DK
Denmark
Prior art keywords
biological effect
medicine
saturated
linear
agent
Prior art date
Application number
DK657689A
Other languages
Danish (da)
English (en)
Inventor
Sven Froekjaer
Tomas Tage Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8148900&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK657689(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK657689A priority Critical patent/DK657689D0/da
Publication of DK657689D0 publication Critical patent/DK657689D0/da
Priority to DK91901713.7T priority patent/DK0509009T3/da
Priority to AU70466/91A priority patent/AU638541B2/en
Priority to EP91901713A priority patent/EP0509009B1/de
Priority to AT91901713T priority patent/ATE121293T1/de
Priority to JP91502039A priority patent/JPH05502669A/ja
Priority to CA002072010A priority patent/CA2072010A1/en
Priority to PCT/DK1990/000343 priority patent/WO1991009597A1/en
Priority to DE69018836T priority patent/DE69018836T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK657689A 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden DK657689D0 (da)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden
DK91901713.7T DK0509009T3 (da) 1989-12-22 1990-12-21 Anvendelse af et middel, hvis hovedbestanddel er et triglycerid, til fremstilling af et lægemiddel
AU70466/91A AU638541B2 (en) 1989-12-22 1990-12-21 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
EP91901713A EP0509009B1 (de) 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält
AT91901713T ATE121293T1 (de) 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
JP91502039A JPH05502669A (ja) 1989-12-22 1990-12-21 腸粘膜に対する生物学的作用を有する薬剤として、主成分がトリグリセリドである物質の使用並びに該薬剤を含有する調製品
CA002072010A CA2072010A1 (en) 1989-12-22 1990-12-21 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
PCT/DK1990/000343 WO1991009597A1 (en) 1989-12-22 1990-12-21 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent
DE69018836T DE69018836T2 (de) 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden

Publications (1)

Publication Number Publication Date
DK657689D0 true DK657689D0 (da) 1989-12-22

Family

ID=8148900

Family Applications (2)

Application Number Title Priority Date Filing Date
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden
DK91901713.7T DK0509009T3 (da) 1989-12-22 1990-12-21 Anvendelse af et middel, hvis hovedbestanddel er et triglycerid, til fremstilling af et lægemiddel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91901713.7T DK0509009T3 (da) 1989-12-22 1990-12-21 Anvendelse af et middel, hvis hovedbestanddel er et triglycerid, til fremstilling af et lægemiddel

Country Status (8)

Country Link
EP (1) EP0509009B1 (de)
JP (1) JPH05502669A (de)
AT (1) ATE121293T1 (de)
AU (1) AU638541B2 (de)
CA (1) CA2072010A1 (de)
DE (1) DE69018836T2 (de)
DK (2) DK657689D0 (de)
WO (1) WO1991009597A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2069073T3 (es) * 1989-04-07 1995-05-01 New England Deaconess Hospital Trigliceridos de cadena corta.
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
DE69403789T2 (de) * 1993-04-23 1997-12-04 Loders Croklaan Bv Nährfette mit verbesserter verdaulichkeit
ES2146734T3 (es) * 1994-03-01 2000-08-16 Procter & Gamble Compresa higienica de seccion triple.
EP0739589B1 (de) * 1995-04-28 2001-06-13 Loders Croklaan B.V. An polyungesättigten Fettsäuren reiche Triglyceride
US6410078B1 (en) 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
AU6869996A (en) * 1995-09-13 1997-04-01 Morten Sloth Weidner Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
WO2020126979A1 (en) 2018-12-17 2020-06-25 Société des Produits Nestlé S.A. Dietary butyrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE407180C (de) * 1920-04-25 1924-12-09 Wilhelm Normann Dr Verfahren zur Herstellung von gemischten Glyceriden
US2879281A (en) * 1955-06-29 1959-03-24 Eastman Kodak Co Trans esterification of triglycerides by means of plural metal catalyst
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
JPS6387988A (ja) * 1986-10-01 1988-04-19 Nisshin Oil Mills Ltd:The 消化吸収性の良い油脂
FR2617161B1 (fr) * 1987-06-29 1989-10-27 Azar Robert Nouveaux glycerides d'acide gras insature et leur procede d'obtention

Also Published As

Publication number Publication date
DE69018836T2 (de) 1995-11-16
AU7046691A (en) 1991-07-24
EP0509009B1 (de) 1995-04-19
ATE121293T1 (de) 1995-05-15
EP0509009A1 (de) 1992-10-21
JPH05502669A (ja) 1993-05-13
AU638541B2 (en) 1993-07-01
CA2072010A1 (en) 1991-06-23
WO1991009597A1 (en) 1991-07-11
DK0509009T3 (da) 1995-08-07
DE69018836D1 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
FR2601675B1 (fr) Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
AR241103A1 (es) "dispositivo de rebajamiento del ala de una butaca anatomica envolvente para el vehiculo automotor o analogo, y butaca que comprende dicho dispositivo".
FI843930A0 (fi) Maerkta konjugat av metalltionein och maolsoekande biologiskt aktiva molekyler.
ES2102367T3 (es) Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
DE3869880D1 (de) Azithromycin und seine derivate als antiprotozoenmittel.
DK393187A (da) Laegemiddel med antitumorvirkning
MA22733A1 (fr) Esters citrates acyles en tant que precurseurs de peracides.
AR240403A1 (es) Procedimiento para la esterilizacion de articulos utilizando vapor de peroxido de hidrogeno
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
ES2069843T3 (es) Utilizacion de baclofen para la obtencion de medicamentos destinados al tratamiento de la angina de pecho.
MX164854B (es) Procedimiento para el tratamiento de copolimero de etileno/monoxido de carbono
DE69015577D1 (de) Apparatus zur Behandlung viskoser Flüssigkeiten.
ES540645A0 (es) Aparato para el tratamiento del plasma.
ES2052166T3 (es) Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
DK657689D0 (da) Middel med biologisk virkning paa tarmslimhinden
DE69004112D1 (de) Anordnung zur Hochspannungsversorgung einer Röntgenröhre.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
GR3005231T3 (de)
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
PT86228A (de) Verfahren zur herstellung von 6alpha,9alpha-difluor-11beta,17alpha-dihydroxy-16alpha-methil-4-pregnen-3,20-dion und dessen derivate
DE59107762D1 (de) Komplexe, enthaltend S(+)-Phenyl-alkansäuren und alpha-Hydroxy-alkansäuren
DK92183A (da) 11beta-chlor-delta15-steroider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
ES2063765T3 (es) Esteres cicloalifaticos insaturados de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
SU855640A1 (ru) Стабилизированный источник посто нного напр жени
ES1006595Y (es) Aparato para el control de tensiones psico-fisiologicas del cuerpo humano.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment